Ritonavir Terminated Phase 3 Trials for Treatment Resistant Disorders / Viral sepsis / Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02247687Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)